RAJANT AND ACUBIS TECHNOLOGIES ANNOUNCE SUCCESSFUL FE1 PEREGRINE AND HAWK DEPLOYMENTS FOR STANWELL’S MEANDU MINE
17. Mai 2022 06:00 ET
|
Rajant Corporation
Malvern, Pennsylvania (USA), May 17, 2022 (GLOBE NEWSWIRE) -- Rajant Corporation, the pioneer of Kinetic Mesh® wireless networks, and Acubis Technologies, a Kinetic Mesh Premier Partner (KMPP) in...
RAJANT ANNOUNCES NEW LTE BREADCRUMB PLUS PERSONNEL AND ASSET TRACKING “MESHTRACER” SOFTWARE AT MINEXPO
13. September 2021 08:00 ET
|
Rajant Corporation
Malvern, Pennsylvania (USA), Sept. 13, 2021 (GLOBE NEWSWIRE) -- Rajant Corporation, the provider of Kinetic Mesh® wireless networks, announces two new products at MINExpo. The latest enhancement...
Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including Bavituximab
12. Februar 2018 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif. and BOSTON, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (“Avid”) and Oncologie, Inc. today announced that the companies have entered into an...
Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)
05. Januar 2018 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company working to improve patient lives by providing high quality biologics...
Peregrine Pharmaceuticals to Present at Biotech Showcase 2018
02. Januar 2018 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company committed to improving patient lives by manufacturing and delivering high...
Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive Officer
26. Dezember 2017 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Dec. 26, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company committed to improving patient lives by manufacturing and delivering high...
Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2018 and Recent Developments
11. Dezember 2017 16:05 ET
|
Peregrine Pharmaceuticals Inc.
-- Avid Bioservices Records Revenues of $12.8 Million in the Second Quarter of FY2018 -- -- Transition to a Dedicated CDMO Business Nearing Completion -- TUSTIN, Calif., Dec. 11, 2017 ...
Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement Agreement
28. November 2017 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif. and CHICAGO, Ill., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP) (“Peregrine”) and Ronin Trading, LLC and SW Investment Management...
Peregrine Pharmaceuticals Announces Appointment of Patrick Walsh to Board of Directors of Peregrine and Avid Bioservices
24. Oktober 2017 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company focused on helping improve patient lives by providing high quality biologics...
Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid Bioservices
19. Oktober 2017 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a company focused on helping improve patient lives by providing high quality biologics...